Immune-mediated skin lesions related to biological disease-modifying antirheumatic drugs: a 22-year experience of a tertiary center.

Ana Martins(Hospital de São João), Miguel Bernardes(Hospital de São João), Daniela Oliveira(Universidade do Porto), Lúcia Costa(Hospital de São João), F. R. Martins(Algarve Biomedical Center), F. Oliveira Pinheiro(Universidade do Porto), M. Rato(Hospital de São João), Rafaela Nicolau(Centro Hospitalar Tondela-Viseu), Sofia Pimenta(Universidade do Porto)
PubMed
July 19, 2023
Cited by 1

Related Papers

Oculomotor nerve palsy, an unusual onset of polyarteritis nodosa
|Reumatologia/Rheumatology|2023|5
SAT0465 FRACTURE RISK ASSESSMENT BY FRAX IN A SYSTEMIC LUPUS ERYTHEMATOSUS PORTUGUESE COHORT
|Annals of the Rheumatic Diseases|2020|4
Recurrent Lupus Pericarditis Treated with Anakinra - a Case Report.
|PubMed|2023|3
Creation and Validation of a Portuguese Version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument
|International Journal of Environmental Research and Public Health|2023|3
SAT0449 SPONDYLOARTHRITIS AND FRACTURE RISK: DOES DXA REALLY HAVE AN IMPACT IN THE RISK OF FRACTURE ESTIMATED BY FRAX?
|Annals of the Rheumatic Diseases|2020|2